Cargando…
Progress toward Health System Readiness for Genome-Based Testing in Canada
(1) Background: Genomic medicine harbors the real potential to improve the health and healthcare journey of patients, care provider experiences, and improve the health system efficiency—even reducing healthcare costs. There is expected to be an exponential growth in medically necessary new genome-ba...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296918/ https://www.ncbi.nlm.nih.gov/pubmed/37366891 http://dx.doi.org/10.3390/curroncol30060408 |
_version_ | 1785063761298587648 |
---|---|
author | Husereau, Don Villalba, Eva Muthu, Vivek Mengel, Michael Ivany, Craig Steuten, Lotte Spinner, Daryl S. Sheffield, Brandon Yip, Stephen Jacobs, Philip Sullivan, Terrence Arshoff, Larry |
author_facet | Husereau, Don Villalba, Eva Muthu, Vivek Mengel, Michael Ivany, Craig Steuten, Lotte Spinner, Daryl S. Sheffield, Brandon Yip, Stephen Jacobs, Philip Sullivan, Terrence Arshoff, Larry |
author_sort | Husereau, Don |
collection | PubMed |
description | (1) Background: Genomic medicine harbors the real potential to improve the health and healthcare journey of patients, care provider experiences, and improve the health system efficiency—even reducing healthcare costs. There is expected to be an exponential growth in medically necessary new genome-based tests and test approaches in the coming years. Testing can also create scientific research and commercial opportunities beyond healthcare decision making. The purpose of this research is to generate a better understanding of Canada’s state of readiness for genomic medicine, and to provide some insights for other healthcare systems. (2) Methods: A mixed-methods approach of a review of the literature and key informant interviews with a purposive sample of experts was used. The health system readiness was assessed using a previously published set of conditions. (3) Results: Canada has created some of the established conditions, but further action needs to be taken to improve the state of readiness for genome-based medicine. The important gaps to be filled are the need for linked information systems and data integration; evaluative processes that are timely and transparent; navigational tools for care providers; dedicated funding to facilitate rapid onboarding and support test development and proficiency testing; and broader engagement with innovation stakeholders beyond care providers and patients. These findings highlight the role of the organizational context, social influence, and other factors that are known to affect the diffusion of innovation within health systems. |
format | Online Article Text |
id | pubmed-10296918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102969182023-06-28 Progress toward Health System Readiness for Genome-Based Testing in Canada Husereau, Don Villalba, Eva Muthu, Vivek Mengel, Michael Ivany, Craig Steuten, Lotte Spinner, Daryl S. Sheffield, Brandon Yip, Stephen Jacobs, Philip Sullivan, Terrence Arshoff, Larry Curr Oncol Article (1) Background: Genomic medicine harbors the real potential to improve the health and healthcare journey of patients, care provider experiences, and improve the health system efficiency—even reducing healthcare costs. There is expected to be an exponential growth in medically necessary new genome-based tests and test approaches in the coming years. Testing can also create scientific research and commercial opportunities beyond healthcare decision making. The purpose of this research is to generate a better understanding of Canada’s state of readiness for genomic medicine, and to provide some insights for other healthcare systems. (2) Methods: A mixed-methods approach of a review of the literature and key informant interviews with a purposive sample of experts was used. The health system readiness was assessed using a previously published set of conditions. (3) Results: Canada has created some of the established conditions, but further action needs to be taken to improve the state of readiness for genome-based medicine. The important gaps to be filled are the need for linked information systems and data integration; evaluative processes that are timely and transparent; navigational tools for care providers; dedicated funding to facilitate rapid onboarding and support test development and proficiency testing; and broader engagement with innovation stakeholders beyond care providers and patients. These findings highlight the role of the organizational context, social influence, and other factors that are known to affect the diffusion of innovation within health systems. MDPI 2023-06-01 /pmc/articles/PMC10296918/ /pubmed/37366891 http://dx.doi.org/10.3390/curroncol30060408 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Husereau, Don Villalba, Eva Muthu, Vivek Mengel, Michael Ivany, Craig Steuten, Lotte Spinner, Daryl S. Sheffield, Brandon Yip, Stephen Jacobs, Philip Sullivan, Terrence Arshoff, Larry Progress toward Health System Readiness for Genome-Based Testing in Canada |
title | Progress toward Health System Readiness for Genome-Based Testing in Canada |
title_full | Progress toward Health System Readiness for Genome-Based Testing in Canada |
title_fullStr | Progress toward Health System Readiness for Genome-Based Testing in Canada |
title_full_unstemmed | Progress toward Health System Readiness for Genome-Based Testing in Canada |
title_short | Progress toward Health System Readiness for Genome-Based Testing in Canada |
title_sort | progress toward health system readiness for genome-based testing in canada |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296918/ https://www.ncbi.nlm.nih.gov/pubmed/37366891 http://dx.doi.org/10.3390/curroncol30060408 |
work_keys_str_mv | AT husereaudon progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT villalbaeva progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT muthuvivek progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT mengelmichael progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT ivanycraig progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT steutenlotte progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT spinnerdaryls progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT sheffieldbrandon progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT yipstephen progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT jacobsphilip progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT sullivanterrence progresstowardhealthsystemreadinessforgenomebasedtestingincanada AT arshofflarry progresstowardhealthsystemreadinessforgenomebasedtestingincanada |